Manuscript Number:
17-0078R3
Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer’s Disease
Disclosures
J. Scott Andrews
-
Equity:Minor shareholder in Eli Lilly and CompanySponsors:Full time employment as research scientist for Eli Lilly and Company
Daniel E. Ball
-
Equity:Minor shareholder in Eli Lilly and CompanySponsors:Full time employment as a Senior Research Advisor for Eli Lilly and Company
Howard G. Birnbaum
-
Consulting Fees:I am employed by Analysis Group, Inc., a company that received funding for this research from Eli Lilly and Company
Urvi Desai
-
Consulting Fees:I am employed by Analysis Group, Inc., a company that received funding for this research from Eli Lilly and Company.
Kristin Kahle-Wrobleski
-
Equity:minor shareholder in Eli Lilly and CompanySponsors:Full time employee of Lilly Research Laboratories, Eli Lilly and Company
Sarah B. King
-
Consulting Fees:At the time of the study, I was employed by Analysis Group, Inc., a company that received funding for this research from Eli Lilly and Company.
Noam Y. Kirson
-
Consulting Fees:I am employed by Analysis Group, a consulting firm that received research funding from the study sponsor, Eli Lilly.
Sophie Schonfeld
-
Consulting Fees:At the time of the study, I was employed by Analysis Group, Inc., a company that received funding for this research from Eli Lilly and Company.
